Suchergebnisse - "Trabaud, Mary-Anne"

PubPharm (96)

1

First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Vautrin, M. | Tombette, F. | Icard, V. | +7

2

Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients

enthalten in: bioRxiv.org | 2024

von Roy, A. | Saade, C. | Josset, L. | +17

3

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

4

Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients

enthalten in: Journal of medical virology | 2023

von Roy, A. | Saade, C. | Josset, L. | +18

5

Effects of remdesivir in patients hospitalised with COVID-19 : a systematic review and individual patient data meta-analysis of randomised controlled trials

enthalten in: The Lancet. Respiratory medicine | 2023

von Amstutz, A. | Speich, B. | Mentré, F. | +32

CommentIn: Lancet Respir Med. 2023 May;11(5):397-398. - PMID 36828007

6

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care (London, England) | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +154

7

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +53

8

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +53

9

Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated healthcare workers

enthalten in: bioRxiv.org | 2023

von Saker, K. | Escuret, V. | Pitiot, V. | +12

10

Determinants of protection against SARS‐CoV‐2 Omicron BA.1 and Delta infections in fully vaccinated outpatients

enthalten in: Journal of Medical Virology | 2023

von Roy, A. | Saade, C. | Josset, L. | +18

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]